[go: up one dir, main page]

MX2009006469A - Metodo de duplicacion del virus de la influenza en cultivo. - Google Patents

Metodo de duplicacion del virus de la influenza en cultivo.

Info

Publication number
MX2009006469A
MX2009006469A MX2009006469A MX2009006469A MX2009006469A MX 2009006469 A MX2009006469 A MX 2009006469A MX 2009006469 A MX2009006469 A MX 2009006469A MX 2009006469 A MX2009006469 A MX 2009006469A MX 2009006469 A MX2009006469 A MX 2009006469A
Authority
MX
Mexico
Prior art keywords
culture
influenza virus
replicating influenza
replicating
isolate
Prior art date
Application number
MX2009006469A
Other languages
English (en)
Inventor
Terri Lee Wasmoen
Peng Gao
Bradley Allen Eddy
Omar Yousif Abdelmagid
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of MX2009006469A publication Critical patent/MX2009006469A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La invención se refiere a un método de selección de un virus de la influenza para desarrollarlo en células de cultivo de tejido, para producir un aislado viral adaptado al cultivo de tejido; la invención también incluye vacunas producidas del aislado.
MX2009006469A 2006-12-15 2007-12-14 Metodo de duplicacion del virus de la influenza en cultivo. MX2009006469A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87528706P 2006-12-15 2006-12-15
US88241206P 2006-12-28 2006-12-28
PCT/US2007/025636 WO2008076371A2 (en) 2006-12-15 2007-12-14 Method for replicating influenza virus in culture

Publications (1)

Publication Number Publication Date
MX2009006469A true MX2009006469A (es) 2009-06-26

Family

ID=39432560

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006469A MX2009006469A (es) 2006-12-15 2007-12-14 Metodo de duplicacion del virus de la influenza en cultivo.

Country Status (14)

Country Link
US (1) US20080187546A1 (es)
EP (1) EP2091561A2 (es)
JP (2) JP2010512748A (es)
KR (1) KR20090088944A (es)
CN (1) CN102766606A (es)
AU (1) AU2007334451A1 (es)
BR (1) BRPI0720304A2 (es)
CA (1) CA2671869A1 (es)
IL (2) IL199169A0 (es)
MX (1) MX2009006469A (es)
NZ (1) NZ578380A (es)
RU (2) RU2491339C2 (es)
SG (1) SG177887A1 (es)
WO (1) WO2008076371A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278846A1 (en) * 2004-06-23 2010-11-04 Ferguson Ian A Nasal-administered vaccines using multi-screened nalt-targeting and phagocytic polypeptide transport sequences
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
JP5257364B2 (ja) 2006-10-25 2013-08-07 インターベツト・インターナシヨナル・ベー・ベー ネコインフルエンザワクチン及び使用方法
CA2723786C (en) 2008-06-27 2020-04-28 Pfizer Inc. Novel saponin-containing adjuvants
WO2010052214A2 (en) * 2008-11-05 2010-05-14 Glaxosmithkline Biologicals S.A. Novel method
BRPI0923448A2 (pt) 2008-12-16 2018-10-09 Baxter Int Inc E Baxter Healthcare S A vírus influenza rearranjado, composição antigênica de vírus influenza rearranjado, vacina, e, métodos para provocar uma resposta imune a pelo menos uma cepa pandêmica de vírus influenza em um indivíduo, para prevenir infecção de um indivíduo por um vírus influenza, e para preparar uma vacina.
SG179037A1 (en) * 2009-09-10 2012-04-27 Merial Ltd New vaccine formulations comprising saponin-containing adjuvants
SG10201501612RA (en) * 2009-12-03 2015-04-29 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
US20110159031A1 (en) * 2009-12-22 2011-06-30 Baxter International Inc. Vaccine to Influenza A Virus
CN102985536B (zh) 2010-04-14 2017-12-05 Emd密理博公司 生产高效价、高纯度的病毒母液的方法及使用其的方法
US9278999B2 (en) * 2012-01-27 2016-03-08 Newport Laboratories Influenza C virus and vaccine
US11633469B2 (en) * 2016-07-15 2023-04-25 The Research Foundation For Microbial Diseases Of Osaka University Reassortant influenza virus production method
CN111108193A (zh) * 2017-09-18 2020-05-05 拜耳医药保健有限公司 使用n-甲基葡糖酰胺及其衍生物灭活病毒的方法
CA3080656A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
US11612648B2 (en) 2018-01-18 2023-03-28 Yisheng Biopharma (Singapore) Pte Ltd Method for adapting influenza viruses to Vero cells
MX2021005685A (es) * 2018-11-15 2021-07-07 Bayer Healthcare Llc Metodos de inactivacion virica para la fabricacion continua de anticuerpos.
US12502426B2 (en) 2019-12-16 2025-12-23 Intervet Inc. Inactivated piscine orthoreovirus vaccine
CN111097044A (zh) * 2019-12-18 2020-05-05 北京华夏兴洋生物科技有限公司 犬型钩端螺旋体、黄疸出血型钩端螺旋体、犬冠状病毒三联灭活疫苗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
WO2005014862A1 (en) * 2003-02-25 2005-02-17 Medimmune Vaccines, Inc. Methods of producing inflenza vaccine compositions
CN1729996A (zh) * 2005-08-03 2006-02-08 中国人民解放军军事医学科学院军事兽医研究所 犬科动物抗犬科动物重要疫病高免血清的制备工艺及制剂

Also Published As

Publication number Publication date
CN102766606A (zh) 2012-11-07
RU2491339C2 (ru) 2013-08-27
CA2671869A1 (en) 2008-06-26
WO2008076371A3 (en) 2008-12-18
IL199169A0 (en) 2010-03-28
NZ578380A (en) 2012-04-27
RU2013117079A (ru) 2014-10-20
SG177887A1 (en) 2012-02-28
AU2007334451A1 (en) 2008-06-26
US20080187546A1 (en) 2008-08-07
JP2010512748A (ja) 2010-04-30
BRPI0720304A2 (pt) 2014-02-04
IL217016A0 (en) 2012-01-31
RU2009126747A (ru) 2011-01-20
EP2091561A2 (en) 2009-08-26
WO2008076371A2 (en) 2008-06-26
KR20090088944A (ko) 2009-08-20
JP2012125261A (ja) 2012-07-05

Similar Documents

Publication Publication Date Title
MX2009006469A (es) Metodo de duplicacion del virus de la influenza en cultivo.
MX2021006342A (es) Mutantes de virus de influenza y usos para los mismos.
MY183385A (en) Production of polio virus at high titers for vaccine production
EP2614140A4 (en) MDCK CELL LINES ADJUSTED TO A SERUM-FREE CULTURE, SUSPENSION CULTURE THEREOF AND METHOD FOR PRODUCING A VACCINE WITH THESE CELLS
EA200970271A1 (ru) Получение вакцин против вируса гриппа без использования куриных эмбрионов
SG10201404101RA (en) Method For Producing Viral Vaccines
NO20054124L (no) Dyre-fri celle kultur metode
UA112768C2 (uk) Європейський штам prrsv
IL193397A0 (en) Hpv antigens, vaccine compositions, and related methods
MX2009008175A (es) Metodos para producir vacunas basadas en levadura.
EA201071086A1 (ru) Усовершенствованный способ получения вакцинных антигенов вируса гриппа
WO2007048089A3 (en) Multi-plasmid system for the production of influenza virus
WO2009140689A8 (en) Method and apparatus for increasing upper-level fish populations
FIC20240033I1 (fi) Influenssa A -viruksen H5 hemagglutiniini pinta-antigeeni, inaktivoitu, valmistettu soluviljelmässä
UA100849C2 (ru) Способ репликации вируса гриппа в культуре
EA201100902A1 (ru) Новый способ получения рнк-вируса
WO2007082734A3 (en) Influenza vaccine
DE602004023238D1 (de) Methoden zur Kultivierung von Antigen presentierenden Immunzellen
EP2012829A4 (en) PROCESS FOR PRODUCING VIRAL VACCINE AND THERAPEUTIC PEPTIDE ANTIGENS
EP2064224A4 (en) TISSUE CULTURE SYSTEM FOR THE PRODUCTION OF HEPATITIS C VIRUS
TW200634156A (en) Neutralizing epitope-based growth enhancing vaccine
WO2009013551A3 (en) Process for preparing viral vaccine
EA201201620A1 (ru) Способ получения рнк-вируса
EP2506873A4 (en) VACCINES AGAINST HUMAN PAPILLOMA (HPV) NOOPLASTIC OR CANNULAR LESIONS, USES THEREOF, AND PROCEDURES AND METHODS THEREFOR
WO2010137021A3 (en) Method of generating connective tissue

Legal Events

Date Code Title Description
FG Grant or registration